Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours

Dutch Biotech Prepares for Acute Kidney Injury Clinical Trial with €116M Fundraise

Il y a 5 jours
The Dutch company AM-Pharma has raised €116M ($133M) to fund a phase III trial of its recombinant protein drug for treating acute kidney injury, a disease with no approved treatments. “This is...
labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours

Swiss Pneumonia Antibiotic Abandoned in Phase III

Il y a 3 jours
The Swiss biotech Polyphor has discontinued two phase III trials of its antibiotic for treating pneumonia after halting both trials due to safety concerns in May. The two phase III trials were testing...
labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours

Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs

Il y a 3 jours
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M ($506M) IPO to fuel its antibody drug programs in cancer, autoimmune diseases, and more. This IPO is one of the biggest...
labiotech.eu
SANOFI AVENTIS
est cité dans une actualité de Labiotech.eu
Il y a 3 jours

Hurry Up! Summer is the Best Season to Start a New Job Hunt! ????

Il y a 4 jours
Hello biotechies, Job hunt frustration? Don’t worry, we’re here to help. Check out the exclusive offer from DNA Script or become a Research Associate at Sanofi. Just starting out? Check out the...
labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 jours

White Paper: A Toolkit for Emerging Biotechs

Il y a 4 jours
Download our white paper we’ve created with the experts at Medpace, a top global CRO, to learn about the challenges emerging biotech companies face from early stage drug development to...
labiotech.eu
Charger plus d'actualités


https://labiotech.eu/

Informations juridiques

SIREN / SIRET - DE Labiotech

Adresse

Berlin Berlin DE Allemagne

Equipes

Je travaille dans cette entreprise